Discovery Labs Notified of PDUFA Date for... ( WARRINGTON Pa. Sept. 28 2011 /- Disco...)

Discovery Labs Notified of PDUFA Date for SURFAXIN®

Date:9/28/2011

WARRINGTON, Pa., Sept. 28, 2011 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO) announced today that the U.S. Food and Drug Administration (FDA) has deemed "complete" the company's Complete Response for SURFAXIN® (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants. The FDA classified the review of the Complete Response as a Class 2 review and established March 6, 2012 as the target action date under the Prescription Drug User Fee Act (PDUFA) to complete its review and potentially grant marketing approval for SURFAXIN.

If approved, SURFAXIN would represent the first synthetic, peptide-containing surfactant for use in neonatal medicine and provide healthcare practitioners with a potential alternative to the currently approved, animal-derived surfactants that today are the standard of care to manage RDS in premature infants.

Discovery Labs will hold a conference call today at 3:00 PM EDT to provide an overview of the SURFAXIN Complete Response filed with the FDA.

Conference Call Details

A live webcast of the conference call, including a slide presentation, is available at https://us.reg.meeting-stream.com/surfaxin-update and www.discoverylabs.com. An archive of the webcast will be available on Discovery Labs Investor Relations web site for approximately 45 days.

For both "listen-only" participants and those who wish to take part in the question and answer portion of the call, the dial-in numbers are (866) 332-5218 (U.S.) or (706) 679-3237 (international). The passcode for the call is 11540927.

An audio replay of the conference call will be available two hours after the call's completion. The dial-in numbers for the replay are (855)
'/>"/>

SOURCE Discovery Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
2. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
3. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
4. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
5. ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia
6. Five Clinical Studies to Receive $2.5 Million Under Foundations 2007 Clinical Discovery Program
7. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
8. FASgen Announces New Discovery for Treatment of Stroke
9. Nobel Prize-Winning Discovery
10. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
11. FASgen Announces a New Discovery in Obesity Research

Post Your Comments:

(Date:5/22/2013)... , May 22, 2013 Team Health Holdings ... the largest suppliers of outsourced healthcare professional staffing and ... the United States , today announced ... Annual Deutsche Bank Healthcare Conference held on May 29, ... begin at 8:00 AM eastern time. Interested investors and ...

(Date:5/22/2013)... N.Y. , May 22, 2013 The Leukemia ... million to Valor Biotherapeutics, LLC, a joint venture ... pre-clinical development, manufacturing, and a Phase I clinical trial ... poor outcomes faced by many patients with indolent lymphomas ... Valor,s protein, IGN002, is a new ...

(Date:5/22/2013)... , May 22, 2013 The new 13-valent ... as the previous version used prior to 2010, the ... Permanente study published today in Vaccine. The ... beginning in 2010 after a series of trials. These ... range of pneumococcal types than the previously used PCV7, ...

Breaking Medicine Technology:Team Health Holdings Inc. to Present at the 38th Annual Deutsche Bank Healthcare Conference 2 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3 The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4 Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2 Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3 Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4

[0] Team Health Holdings Inc. to Present at the 38th Annual Deutsche Bank Healthcare Conference [0] The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients [0] Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine

... Attend ROTH Fall Conference at Maui, Hawaii From September 1 -... -- CHENGDU, China, Aug. 30 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by ...

... 30 Phase 3 safety and efficacy data comparing tapentadol ... in patients with moderate to severe chronic osteoarthritis knee pain ... addition, this study compared oxycodone controlled release (CR) to placebo ... ER vs. Placebo The study demonstrated ...

Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain

(Date:5/22/2013)... New York, New York (PRWEB) May 22, 2013 ... a metal-on-metal version of the DePuy Pinnacle Hip Replacement ... underway in Texas Federal Court, Bernstein Liebhard LLP reports. ... Court has directed DePuy Orthopaedics to produce monitoring reports ... government into the company’s medical device marketing practices. ...

(Date:5/22/2013)... Diversity Focus and Handicap This Productions announce ... promotes awareness that physical disabilities do not stop people ... be held Friday, June 14th at 7:30 p.m. at ... Handicap This! can be purchased at http://www.diversityfocus.org . ... to which their mind is handicap accessible. Mike ...

(Date:5/22/2013)... May 22, 2013 Twenty student-led startup ... year participating in an intensive startup accelerator designed to ... or services and create local jobs as part of ... year the Edson initiative offers approximately 20 student teams ... mentorship and training to launch their for-profit, more-than-profit or ...

(Date:5/22/2013)... University of Michigan study challenges previous research that ... , The study, a collaboration between researchers at ... looks deeper into the controversial argument over whether ... for pitchers of the same race. It found ... Jason Winfree, associate professor of sport management at ...

(Date:5/22/2013)... (HealthDay News) -- Over the next two decades, the ... expected to more than double, topping more than $180 ... main factor driving the increase: an aging population. The ... American Stroke Association, was published May 22 in the ... the health care system," Dr. Bruce Ovbiagele, chairman of ...

[0] DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation [0] Handicap This! Comes to Marion, Iowa [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort [0] U-M study challenges notion that umpires call more strikes for pitchers of same race [0] Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report

... A community-based maternal health delivery strategy known as the ... maternal health care services for internally displaced woman in ... at the Johns Hopkins Bloomberg School of Public Health. ... in the proportion of women assisted at delivery by ...

... Reporter , TUESDAY, Aug. 3 (HealthDay News) -- America,s waistline ... every 10 adults (26.7 percent) is now statistically obese, up ... report released Tuesday. The report, from the ... that between 2007-2009, the number of U.S. states where at ...

... the residents of Florida, Maine and Massachusetts believe the ... 100 years (81 percent, 78 percent and 84 percent, ... greenhouse gas emissions, according to new public opinion research ... Woods Institute for the Environment at Stanford University. ...

... at Boston University School of Medicine (BUSM) have reported ... a greater likelihood of developing breast cancer than nonusers. ... Cancer Epidemiology Biomarkers and Prevention , were based on ... large follow-up study of 59,000 African American women from ...

... State University biologist and mathematician have joined forces to ... of the hormone prolactin from the pituitary gland, research ... of disorders, including infertility. Marc Freeman, the ... Research Professor Emeritus, and mathematics Professor Richard Bertram have ...

... famed for their ability to mimic sounds and now researchers ... male contact calls when deciding on a mate. The research, ... difference between birds ,songs, and ,calls,. Parrots are ... ability to quickly learn and mimic new sounds, but the ...

Cached Medicine News:Health News:Mobile obstetrics project improves health of mothers in Eastern Burma 2 Health News:Number of Obese Adults Keeps Rising, CDC Says 2 Health News:Number of Obese Adults Keeps Rising, CDC Says 3 Health News:New state surveys affirm Americans' support for government action on climate change 2 Health News:New state surveys affirm Americans' support for government action on climate change 3 Health News:Oral contraceptive use associated with increased risk of breast cancer 2 Health News:FSU study takes novel approach to understanding pituitary function 2 Health News:FSU study takes novel approach to understanding pituitary function 3 Health News:'Virtual mates' reveal role of romance in parrot calls 2

Mobile obstetrics project improves health of mothers in Eastern Burma Number of Obese Adults Keeps Rising, CDC Says New state surveys affirm Americans' support for government action on climate change Oral contraceptive use associated with increased risk of breast cancer FSU study takes novel approach to understanding pituitary function 'Virtual mates' reveal role of romance in parrot calls

... the ureter to be dilated immediately below ... base of the balloon allows fluoroscopic confirmation ... sterile in peel-open packages. Intended for one-time ... Straight Safety Wire Guide [.038 inch (0.97 ...

Used during the performance of balloon dilation procedures to inflate and deflate the balloon and measure the pressure within the balloon during the procedure. Supplied sterile in peel-open packages....

... Small 6.9 Fr Diameter with Two Large ... USA Series MICRO-6 Semi-Rigid Ureteroscope is the ... for diagnostic and therapeutic procedures. The ACMI ... time for procedures with minimal or no ...

Smooth, contoured visual obturator provides less traumatic insertion through the urethra and into the bladder....

Medicine Products:

Tipless Balloon Catheter Set Inflation Device Set USA Series MICRO-6 Semi-Rigid Ureteroscope S-Series Cystourethroscope Visual Obturator